Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

The Global Spine Care Initiative: World Spine Care executive summary on reducing spine-related disability in low- and middle-income communities.

Haldeman S, Nordin M, Chou R, Côté P, Hurwitz EL, Johnson CD, Randhawa K, Green BN, Kopansky-Giles D, Acaroğlu E, Ameis A, Cedraschi C, Aartun E, Adjei-Kwayisi A, Ayhan S, Aziz A, Bas T, Blyth F, Borenstein D, Brady O, Brooks P, Camilleri C, Castellote JM, Clay MB, Davatchi F, Dudler J, Dunn R, Eberspaecher S, Emmerich J, Farcy JP, Fisher-Jeffes N, Goertz C, Grevitt M, Griffith EA, Hajjaj-Hassouni N, Hartvigsen J, Hondras M, Kane EJ, Laplante J, Lemeunier N, Mayer J, Mior S, Mmopelwa T, Modic M, Moss J, Mullerpatan R, Muteti E, Mwaniki L, Ngandeu-Singwe M, Outerbridge G, Rajasekaran S, Shearer H, Smuck M, Sönmez E, Tavares P, Taylor-Vaisey A, Torres C, Torres P, van der Horst A, Verville L, Vialle E, Kumar GV, Vlok A, Watters W 3rd, Wong CC, Wong JJ, Yu H, Yüksel S.

Eur Spine J. 2018 Sep;27(Suppl 6):776-785. doi: 10.1007/s00586-018-5722-x. Epub 2018 Aug 27.

PMID:
30151809
2.

The Global Spine Care Initiative: methodology, contributors, and disclosures.

Johnson CD, Haldeman S, Nordin M, Chou R, Côté P, Hurwitz EL, Green BN, Kopansky-Giles D, Randhawa K, Cedraschi C, Ameis A, Acaroğlu E, Aartun E, Adjei-Kwayisi A, Ayhan S, Aziz A, Bas T, Blyth F, Borenstein D, Brady O, Brooks P, Camilleri C, Castellote JM, Clay MB, Davatchi F, Dudler J, Dunn R, Eberspaecher S, Emmerich J, Farcy JP, Fisher-Jeffes N, Goertz C, Grevitt M, Griffith EA, Hajjaj-Hassouni N, Hartvigsen J, Hondras M, Kane EJ, Laplante J, Lemeunier N, Mayer J, Mior S, Mmopelwa T, Modic M, Moss J, Mullerpatan R, Muteti E, Mwaniki L, Ngandeu-Singwe M, Outerbridge G, Rajasekaran S, Shearer H, Smuck M, Sönmez E, Tavares P, Taylor-Vaisey A, Torres C, Torres P, van der Horst A, Verville L, Vialle E, Kumar GV, Vlok A, Watters W 3rd, Wong CC, Wong JJ, Yu H, Yüksel S.

Eur Spine J. 2018 Sep;27(Suppl 6):786-795. doi: 10.1007/s00586-018-5723-9. Epub 2018 Aug 27.

PMID:
30151808
3.

The Global Spine Care Initiative: model of care and implementation.

Johnson CD, Haldeman S, Chou R, Nordin M, Green BN, Côté P, Hurwitz EL, Kopansky-Giles D, Acaroğlu E, Cedraschi C, Ameis A, Randhawa K, Aartun E, Adjei-Kwayisi A, Ayhan S, Aziz A, Bas T, Blyth F, Borenstein D, Brady O, Brooks P, Camilleri C, Castellote JM, Clay MB, Davatchi F, Dudler J, Dunn R, Eberspaecher S, Emmerich J, Farcy JP, Fisher-Jeffes N, Goertz C, Grevitt M, Griffith EA, Hajjaj-Hassouni N, Hartvigsen J, Hondras M, Kane EJ, Laplante J, Lemeunier N, Mayer J, Mior S, Mmopelwa T, Modic M, Moss J, Mullerpatan R, Muteti E, Mwaniki L, Ngandeu-Singwe M, Outerbridge G, Rajasekaran S, Shearer H, Smuck M, Sönmez E, Tavares P, Taylor-Vaisey A, Torres C, Torres P, van der Horst A, Verville L, Vialle E, Kumar GV, Vlok A, Watters W 3rd, Wong CC, Wong JJ, Yu H, Yüksel S.

Eur Spine J. 2018 Sep;27(Suppl 6):925-945. doi: 10.1007/s00586-018-5720-z. Epub 2018 Aug 27.

PMID:
30151805
4.

The Global Spine Care Initiative: a systematic review for the assessment of spine-related complaints in populations with limited resources and in low- and middle-income communities.

Nordin M, Randhawa K, Torres P, Yu H, Haldeman S, Brady O, Côté P, Torres C, Modic M, Mullerpatan R, Cedraschi C, Chou R, Acaroğlu E, Hurwitz EL, Lemeunier N, Dudler J, Taylor-Vaisey A, Sönmez E.

Eur Spine J. 2018 Sep;27(Suppl 6):816-827. doi: 10.1007/s00586-017-5446-3. Epub 2018 Feb 28. Review.

PMID:
29492717
5.

Efficacy, Safety and Mucosal Healing of Methotrexate in a Large Longitudinal Cohort of Inflammatory Bowel Disease Patients.

Rouiller-Braunschweig C, Fournier N, Pittet V, Dudler J, Michetti P.

Digestion. 2017 Nov;96(4):220-227. doi: 10.1159/000482007. Epub 2017 Oct 24.

6.

Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis.

Alpizar-Rodriguez D, Mueller RB, Möller B, Dudler J, Ciurea A, Zufferey P, Kyburz D, Walker UA, von Mühlenen I, Roux-Lombard P, Mahler M, Lamacchia C, Courvoisier DS, Gabay C, Finckh A.

Rheumatology (Oxford). 2017 Sep 1;56(9):1579-1585. doi: 10.1093/rheumatology/kex239.

PMID:
28859327
7.

[Doctor : « I hurt everywhere »].

Eichenberger C, Dudler J, Marion-Veyron R, Gonthier A, Cornuz J, Favrat B.

Rev Med Suisse. 2016 Nov 2;12(537):1852-1856. French.

PMID:
28696623
8.

Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).

Reginster JY, Dudler J, Blicharski T, Pavelka K.

Ann Rheum Dis. 2017 Sep;76(9):1537-1543. doi: 10.1136/annrheumdis-2016-210860. Epub 2017 May 22.

9.

Dr. Wiland, et al, reply.

Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.

J Rheumatol. 2017 Feb;44(2):259. doi: 10.3899/jrheum.161405. No abstract available.

PMID:
28148758
10.

The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.

Alpizar-Rodriguez D, Brulhart L, Mueller RB, Möller B, Dudler J, Ciurea A, Walker UA, Von Mühlenen I, Kyburz D, Zufferey P, Mahler M, Bas S, Gascon D, Lamacchia C, Roux-Lombard P, Lauper K, Nissen MJ, Courvoisier DS, Gabay C, Finckh A.

Clin Rheumatol. 2017 Mar;36(3):677-682. doi: 10.1007/s10067-017-3547-3. Epub 2017 Jan 21.

PMID:
28110385
11.

The Effect of Reduced or Withdrawn Etanercept-methotrexate Therapy on Patient-reported Outcomes in Patients with Early Rheumatoid Arthritis.

Wiland P, Dudler J, Veale D, Tahir H, Pedersen R, Bukowski J, Vlahos B, Williams T, Gaylord S, Kotak S.

J Rheumatol. 2016 Jul;43(7):1268-77. doi: 10.3899/jrheum.151179. Epub 2016 Jun 1.

PMID:
27252426
12.

The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologists.

Boehncke WH, Anliker MD, Conrad C, Dudler J, Hasler F, Hasler P, Häusermann P, Kyburz D, Laffitte E, Michel BA, Möller B, Navarini AA, Villiger PM, Yawalkar N, Gabay C.

Dermatology. 2015;230(1):75-81. doi: 10.1159/000367688. Epub 2015 Jan 6.

13.

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK).

Mueller RB, Gengenbacher M, Richter S, Dudler J, Möller B, von Kempis J.

Arthritis Res Ther. 2016 Apr 14;18:88. doi: 10.1186/s13075-016-0985-2.

14.

Fear of impending fractures: when to refer? A case-based review.

Kronisch C, Balagué F, Dudler J.

Clin Rheumatol. 2015 Jul;34(7):1303-9. doi: 10.1007/s10067-013-2461-6. Epub 2014 Jan 3. Review.

PMID:
24384823
15.

Cranial neuropathies in granulomatosis with polyangiitis (Wegener's): a case-based review.

Söderström A, Revaz S, Dudler J.

Clin Rheumatol. 2015 Mar;34(3):591-6. doi: 10.1007/s10067-013-2420-2. Epub 2013 Dec 19. Review.

PMID:
24352751
16.

RAISE - rheumatoid arthritis independent Swiss treatment expectations and outcome: results for the abatacept subpopulation.

Dudler J, Tuerk R, Handschin T, Forster A.

Swiss Med Wkly. 2013 Dec 6;143:w13849. doi: 10.4414/smw.2013.13849. eCollection 2013.

17.

[Drug therapy of pain: reason overwhelmed by emotion?].

Theiler R, Dudler J.

Rev Med Suisse. 2013 Oct 9;9(401):1846-53. Review. French.

PMID:
24191420
18.

Morphometric vertebral assessments via the use of dual X-ray absorptiometry for the evaluation of radiographic damage in ankylosing spondylitis: a pilot study.

Aubry-Rozier B, Hans D, Krieg MA, Lamy O, Dudler J.

J Clin Densitom. 2014 Jan-Mar;17(1):190-4. doi: 10.1016/j.jocd.2013.09.004. Epub 2013 Oct 22.

PMID:
24161790
19.

Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.

Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U; Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis.

Arthritis Rheum. 2013 Dec;65(12):3096-106. doi: 10.1002/art.38140.

20.

[Imaging in low back pain: limits and reflexions].

Balagué F, Dudler J.

Rev Med Suisse. 2013 Jun 26;9(392):1351-2, 1354-6, 1358-9. French.

PMID:
23882912
21.

Disease activity in rheumatoid arthritis patients at initiation of biologic agents and 1 year of treatment: results from the Swiss SCQM registry.

Zufferey P, Dudler J, Scherer A, Finckh A.

Joint Bone Spine. 2013 Mar;80(2):160-4. doi: 10.1016/j.jbspin.2012.05.003. Epub 2012 Jul 4.

PMID:
22771133
22.

Use of abatacept in rheumatoid arthritis.

von Kempis J, Dudler J, Hasler P, Kyburz D, Tyndall A, Zufferey P, Villiger PM.

Swiss Med Wkly. 2012 May 11;142:w13581. doi: 10.4414/smw.2012.13581. eCollection 2012. Review.

23.

[Diffuse sclerosing osteomyelitis of the mandible and SAPHO].

Aubry-Rozier B, Basch A, Dudler J.

Rev Med Interne. 2012 Jun;33(6):e34-7. doi: 10.1016/j.revmed.2011.07.011. Epub 2012 May 8. French.

PMID:
22572588
24.

Physical activity and energy expenditure in rheumatoid arthritis patients and matched controls.

Henchoz Y, Bastardot F, Guessous I, Theler JM, Dudler J, Vollenweider P, So A.

Rheumatology (Oxford). 2012 Aug;51(8):1500-7. doi: 10.1093/rheumatology/kes067. Epub 2012 Apr 25.

PMID:
22539478
25.

Steroids for LBP - from rationale to inconvenient truth.

Balagué F, Piguet V, Dudler J.

Swiss Med Wkly. 2012 Apr 11;142:w13566. doi: 10.4414/smw.2012.13566. eCollection 2012. Review.

26.

Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?

Stoll D, Dudler J, Lamy O, Hans D, Krieg MA, Aubry-Rozier B.

Osteoporos Int. 2013 Feb;24(2):495-500. doi: 10.1007/s00198-012-1962-5. Epub 2012 Mar 17.

PMID:
22426953
27.

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.

Finckh A, Möller B, Dudler J, Walker UA, Kyburz D, Gabay C; physicians of the Swiss Clinical Quality Management for Rheumatoid Arthritis; physicians of SCQM-RA.

Ann Rheum Dis. 2012 Oct;71(10):1680-5. Epub 2012 Mar 14.

28.

[Interstitial lung disease in rheumatoid arthritis].

Froidevaux-Janin S, Dudler J, Nicod LP, Lazor R.

Rev Med Suisse. 2011 Nov 23;7(318):2272-7. Review. French.

PMID:
22400361
29.

Safety and efficacy of ocrelizumab in combination with methotrexate in MTX-naive subjects with rheumatoid arthritis: the phase III FILM trial.

Stohl W, Gomez-Reino J, Olech E, Dudler J, Fleischmann RM, Zerbini CA, Ashrafzadeh A, Grzeschik S, Bieraugel R, Green J, Francom S, Dummer W.

Ann Rheum Dis. 2012 Aug;71(8):1289-96. doi: 10.1136/annrheumdis-2011-200706. Epub 2012 Feb 2.

30.

Shrinking lung syndrome successfully treated with rituximab and cyclophosphamide.

Langenskiöld E, Bonetti A, Fitting JW, Heinzer R, Dudler J, Spertini F, Lazor R.

Respiration. 2012;84(2):144-9. doi: 10.1159/000334947. Epub 2012 Jan 31.

31.

High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.

Stoll D, Dudler J, Lamy O, Hans D, So A, Krieg MA, Aubry-Rozier B.

Swiss Med Wkly. 2011 May 27;141:w13196. doi: 10.4414/smw.2011.13196. eCollection 2011.

32.

Biologics in rheumatoid arthritis--recommendations for Swiss practice.

Dudler J, Möller B, Michel BA, Villiger PM.

Swiss Med Wkly. 2011 May 10;141:w13189. doi: 10.4414/smw.2011.13189. eCollection 2011.

33.

[Arthritis, erythema nodosum and genital ulcerations. Behçet disease].

Arnold C, Revaz S, Dudler J.

Praxis (Bern 1994). 2011 Apr 13;100(8):483-6. doi: 10.1024/1661-8157/a000499. German.

PMID:
21484713
34.

Terminal phalangeal osteosclerosis and rheumatoid arthritis.

Currat M, Aubry-Rozier B, Dudler J.

CMAJ. 2011 Apr 19;183(7):E428. doi: 10.1503/cmaj.091189. Epub 2011 Feb 14. No abstract available.

35.

Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion.

Walker UA, Courvoisier DS, Dudler J, Aeberli D, von Kempis J, Scherer A, Finckh A; Swiss Clinical Quality Management Programme in Rheumatic Diseases.

Rheumatology (Oxford). 2011 Jan;50(1):243-4. doi: 10.1093/rheumatology/keq258. Epub 2010 Aug 17. No abstract available.

36.

Swiss consensus statement: Recommendations for optimising re-treatment with MabThera (rituximab) in rheumatoid arthritis.

Dudler J, Finckh A, Kyburz D, Langenegger T, Möller B, Schmiedel U, Walker UA.

Swiss Med Wkly. 2010 Jul 16;140:w13073. doi: 10.4414/smw.2010.13073. eCollection 2010.

37.

Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients.

Finckh A, Dudler J, Wermelinger F, Ciurea A, Kyburz D, Gabay C, Bas S; physicians of SCQM.

Joint Bone Spine. 2010 Jul;77(4):313-8. doi: 10.1016/j.jbspin.2010.02.021. Epub 2010 May 14.

PMID:
20471890
38.

[Late-onset rheumatoid arthritis: clinical presentation and management].

Dudler J.

Rev Med Suisse. 2010 Mar 17;6(240):542, 544, 546. French.

PMID:
20408458
39.

[Prevention of cortisone-induced osteoporosis: who, when and what?].

Aubry-Rozier B, Lamy O, Dudler J.

Rev Med Suisse. 2010 Feb 10;6(235):307-13. French.

PMID:
20218181
40.

[Rheumatoid arthritis and ankylosing spondylitis-rheumatologic highlights 2009].

Dudler J.

Rev Med Suisse. 2010 Jan 20;6(232):141-2, 144. French.

PMID:
20170034
41.

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?

Finckh A, Ciurea A, Brulhart L, Möller B, Walker UA, Courvoisier D, Kyburz D, Dudler J, Gabay C; Arthritis.

Ann Rheum Dis. 2010 Feb;69(2):387-93. doi: 10.1136/ard.2008.105064. Epub 2009 May 4.

42.

[Inflammatory back pain].

Dudler J.

Rev Med Suisse. 2009 Mar 11;5(194):572-4, 576. Review. French.

PMID:
19405272
43.

[Arthrocentesis and joint infiltration].

Gachoud D, Guinot-Bourquin S, Monti M, Dudler J.

Rev Med Suisse. 2008 Oct 29;4(177):2330-2, 2334-6. Review. French.

PMID:
19055150
44.

Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides.

Jandus C, Bioley G, Rivals JP, Dudler J, Speiser D, Romero P.

Arthritis Rheum. 2008 Aug;58(8):2307-17. doi: 10.1002/art.23655.

45.

Neurological and pulmonary adverse effects of subcutaneous methotrexate therapy.

Sommer WH, Ganiere V, Gachoud D, Keta A, Abou-Hajar A, Dudler J, Aujesky D.

Scand J Rheumatol. 2008 Jul-Aug;37(4):306-9. doi: 10.1080/03009740801908001.

PMID:
18612932
46.

[Diagnosis and treatment of rheumatoid vasculitis and other systemic complications of rheumatoid arthritis].

Revaz S, Dudler J.

Rev Med Suisse. 2008 Mar 19;4(149):712, 714, 716-7. Review. French.

PMID:
18472732
47.

[Adult-onset Still's disease].

Dudler J, Revaz S.

Rev Med Suisse. 2008 Mar 19;4(149):702, 704-6. Review. French.

PMID:
18472730
48.

[Rheumatoid arthritis and ankylosing spondylitis--rheumatologic highlights 2007].

Dudler J, Aubry-Rozier B.

Rev Med Suisse. 2008 Jan 9;4(139):67-8, 70-1. Review. French.

PMID:
18251219
49.

Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy.

Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, Villiger PM, Zellweger JP.

Swiss Med Wkly. 2007 Nov 3;137(43-44):620-2. No abstract available.

50.

Indoleamine 2,3-dioxygenase gene transfer prolongs cardiac allograft survival.

Li J, Meinhardt A, Roehrich ME, Golshayan D, Dudler J, Pagnotta M, Trucco M, Vassalli G.

Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3415-23. Epub 2007 Oct 12.

Supplemental Content

Loading ...
Support Center